LinkedIn Profile

Access Microbix Biosystems historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Sector Industry
private:microbixbiosystems 342321 May 29th, 2019 12:00AM Microbix 1.6K 60.00 Open Biotechnology May 29th, 2019 07:51PM May 29th, 2019 07:51PM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Open Open 265 Watline Ave. Mississauga Ontario CA L4Z 1P3 Health Care Pharmaceuticals & Biotechnology Health Care
private:microbixbiosystems 342321 Feb 17th, 2018 12:00AM Microbix 1.3K 56.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Health Care Pharmaceuticals & Biotechnology Health Care
private:microbixbiosystems 342321 Feb 16th, 2018 12:00AM Microbix 1.3K 56.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Health Care Pharmaceuticals & Biotechnology Health Care
private:microbixbiosystems 342321 Feb 15th, 2018 12:00AM Microbix 1.3K 56.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Health Care Pharmaceuticals & Biotechnology Health Care
private:microbixbiosystems 342321 Feb 14th, 2018 12:00AM Microbix 1.3K 56.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Health Care Pharmaceuticals & Biotechnology Health Care
private:microbixbiosystems 342321 Feb 13th, 2018 12:00AM Microbix 1.3K 56.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Health Care Pharmaceuticals & Biotechnology Health Care
private:microbixbiosystems 342321 Feb 12th, 2018 12:00AM Microbix 1.3K 56.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Health Care Pharmaceuticals & Biotechnology Health Care
private:microbixbiosystems 342321 Feb 11th, 2018 12:00AM Microbix 1.3K 56.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Health Care Pharmaceuticals & Biotechnology Health Care
private:microbixbiosystems 342321 Feb 10th, 2018 12:00AM Microbix 1.3K 56.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Health Care Pharmaceuticals & Biotechnology Health Care
private:microbixbiosystems 342321 Feb 9th, 2018 12:00AM Microbix 1.3K 56.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: VIRUSMAX Influenza Virus Yield Enhancement Technology LumiSort™ Gender Selection Technology Kinlytic® (Urokinase) Thrombolytic Drug Health Care Pharmaceuticals & Biotechnology Health Care

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.